Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5 | 35 | 14 | 10 | 26 |
| TOTAL | $5 | $35 | $14 | $10 | $26 |
| Non-Current Assets | |||||
| Intangibles | 134 | 124 | 115 | 116 | 113 |
| TOTAL | $134 | $124 | $115 | $116 | $113 |
| Total Assets | $139 | $159 | $129 | $126 | $139 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 48 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 667 | 312 | 433 | 210 | 330 |
| Accrued Expenses | N/A | 123 | N/A | N/A | N/A |
| Other current liabilities | 411 | 50 | 65 | 44 | 1,015 |
| TOTAL | $1,931 | $1,244 | $1,229 | $1,116 | $3,244 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 13 | 22 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,931 | $1,244 | $1,229 | $1,116 | $3,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 88,882 | 85,783 | 177,956 | 174,963 | 166,493 |
| Common Shares | 87 | 82 | 177 | 173 | 145 |
| Retained earnings | -18,921 | -18,299 | -16,960 | -16,298 | -15,699 |
| Other shareholders' equity | 0 | 0 | -694 | -694 | -636 |
| TOTAL | $-1,792 | $-1,085 | $-1,100 | $-990 | $-3,105 |
| Total Liabilities And Equity | $139 | $159 | $129 | $126 | $139 |